Manju George
Palm Beach Gardens, FLNPI 1912054446
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 18.3%. 2025 is the largest year on record at $14,630, more than ten times the $756 reported in 2019.
Across 408 payments — averaging $69.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$5K
- Arcutis Biotherapeutics, Inc.$5K
- Dermavant Sciences, Inc.$4K
- Incyte Corporation$3K
- Abeona Therapeutics, Inc.$3K
- Almirall LLC$1K
- plus $7K from 23 others
What the payments were for
- Consulting fees$14,45051%
- Speaking & faculty fees$3,65713%
- Travel & lodging$1,0314%
- Food & beverage$9,02632%
- Education$2801%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 39 | $5,193 |
| Arcutis Biotherapeutics, Inc. | 23 | $4,764 |
| Dermavant Sciences, Inc. | 30 | $3,520 |
| Incyte Corporation | 27 | $3,409 |
| Abeona Therapeutics, Inc. | 2 | $2,850 |
| Almirall LLC | 24 | $1,484 |
| Regeneron Healthcare Solutions, Inc. | 51 | $1,420 |
| LEO Pharma Inc. | 9 | $1,351 |
| Sanofi | 31 | $791 |
| Sun Pharmaceutical Industries Inc. | 37 | $755 |
| Galderma Laboratories, L.p. | 40 | $733 |
| Organon | 18 | $411 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 19 | $344 |
| LNHC, Inc | 13 | $316 |
| Sanofi-aventis U.S. LLC | 3 | $192 |
| Amgen | 8 | $166 |
| Lilly USA, LLC | 4 | $144 |
| Novartis | 5 | $129 |
| Journey Medical Corporation | 7 | $123 |
| AbbVie | 4 | $92 |
| Mayne Pharma Commercial LLC | 3 | $70 |
| Verrica Pharmaceuticals Inc. | 3 | $54 |
| Dermira, Inc. | 2 | $31 |
| UCB, Inc. | 1 | $24 |
| Gilead | 1 | $20 |
| Medtronic | 1 | $19 |
| Strata Skin Sciences, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.